November 30, 2022
  • Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of Tuesday, meaning a deal could be worth as much as $20 billion including a takeover premium. (Article here)